LON:BPCP BioPharma Credit (BPCP) Share Price, News & Analysis → Buy Friday, Sell Monday, No Exceptions (From DTI) (Ad) Free BPCP Stock Alerts GBX 71.60 +0.60 (+0.85%) (As of 03/27/2024 09:01 PM ET) Add Share Share Today's Range 71.60▼ 7350-Day Range 66.30▼ 7652-Week Range 64.18▼ 80.81Volume11,458 shsAverage Volume17,408 shsMarket Capitalization£980.92 millionP/E Ratio1,193.33Dividend Yield0.10%Price TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get BioPharma Credit alerts: Email Address Ad DTImy top trade on these 9 tickersThis indicator is uniquely designed to spot the most significant moves in the top stocks out there (and according to our backtesting it has historically nailed these moves with a stunning 90% accuracy). Now, most folks have been saying NVDA is way overbought or overpriced. They didn’t want to “buy at the top” 6 weeks ago… Or again 4 weeks ago… or again 2 weeks ago… And it’s not their fault! That’s what all the talking heads were saying too. But the Apex Indicator would have clearly shown that these were opportunities to buy. And, sure enough, Nvidia slammed through the recommended targets again and again.Click Here for this Powerful Workshop About BioPharma Credit Stock (LON:BPCP)BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.Read More BPCP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BPCP Stock News HeadlinesMarch 20, 2024 | americanbankingnews.comBioPharma Credit (LON:BPCP) Stock Price Down 3.4%See More Headlines Receive BPCP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorN/A Industry N/A Sub-IndustryN/A Current SymbolLON:BPCP CUSIPN/A CIKN/A Webwww.bpcruk.com Phone44 13 9247 7500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.06 Trailing P/E Ratio1,193.33 Forward P/E RatioN/A P/E GrowthN/ANet Income£185.07 million Net Margins83.84% Pretax MarginN/A Return on Equity13.65% Return on Assets8.50% Debt Debt-to-Equity RatioN/A Current Ratio21.75 Quick Ratio14.07 Sales & Book Value Annual Sales£220.74 million Price / Sales4.44 Cash FlowGBX 0.73 per share Price / Cash Flow98.00 Book ValueGBX 102 per share Price / Book0.70Miscellaneous Outstanding Shares1,370,000,000Free FloatN/AMarket Cap£980.92 million OptionableNot Optionable Beta0.22 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Pedro Gonzalez de CosioInvestment ManagerMr. Pablo Gerardo Legorreta (Age 59)Investment Manager Mr. Martin G. Friedman (Age 59)Investment Manager BPCP Stock Analysis - Frequently Asked Questions How have BPCP shares performed in 2024? BioPharma Credit's stock was trading at GBX 66.30 on January 1st, 2024. Since then, BPCP shares have increased by 8.0% and is now trading at GBX 71.60. View the best growth stocks for 2024 here. Is BioPharma Credit a good dividend stock? BioPharma Credit (LON:BPCP) pays an annual dividend of GBX 0.07 per share and currently has a dividend yield of 7.34%. BPCP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 116.67%. Payout ratios above 75% are not desirable because they may not be sustainable. How do I buy shares of BioPharma Credit? Shares of BPCP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:BPCP) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.